000			01676 a2200445 4500
005			20250516063207.0
264		0	_c20120214
008			201202s 0 0 eng d
022			_a1558-2264
024	7		_a10.1016/j.ccl.2011.08.012 _2doi
040			_aNLM _beng _cNLM
100	1		_aJacoby, Daniel
245	0	0	_aNatural history of end-stage LV dysfunction: has it improved from the classic Franciosa and Cohn Graph? _h[electronic resource]
260			_bCardiology clinics _cNov 2011
300			_a485-95 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdrenergic beta-Antagonists _xtherapeutic use
650	0	4	_aAngiotensin-Converting Enzyme Inhibitors _xtherapeutic use
650	0	4	_aBenzazepines _xtherapeutic use
650	0	4	_aCardiac Resynchronization Therapy
650	0	4	_aDefibrillators, Implantable
650	0	4	_aHeart Failure _xdiagnosis
650	0	4	_aHeart-Assist Devices
650	0	4	_aHumans
650	0	4	_aHydralazine _xtherapeutic use
650	0	4	_aIvabradine
650	0	4	_aMineralocorticoid Receptor Antagonists _xtherapeutic use
650	0	4	_aNitrates _xtherapeutic use
650	0	4	_aRenin-Angiotensin System _xphysiology
650	0	4	_aRisk Factors
650	0	4	_aSurvival Analysis
650	0	4	_aSympathetic Nervous System _xphysiology
650	0	4	_aTreatment Outcome
650	0	4	_aVentricular Dysfunction, Left _xetiology
650	0	4	_aVentricular Remodeling _xphysiology
700	1		_aAlbajrami, Oltjan
700	1		_aBellumkonda, Lavanya
773	0		_tCardiology clinics _gvol. 29 _gno. 4 _gp. 485-95
856	4	0	_uhttps://doi.org/10.1016/j.ccl.2011.08.012 _zAvailable from publisher's website
999			_c21291760 _d21291760